Finding 1221268 (2024-008)

Material Weakness Repeat Finding
Requirement
AB
Questioned Costs
-
Year
2024
Accepted
2026-06-30

AI Summary

  • Core Issue: The Organization charged 100% of the Executive Director's wages to the grant, violating federal limits.
  • Impacted Requirements: Compliance with federal guidelines for allowable costs and timely reporting was not met.
  • Recommended Follow-Up: Implement controls to review Financial Status Reports (FSR) for compliance before submission.

Finding Text

2024-008 Significant Deficiency – Allowable Wages Criteria and Condition: In order to stay in compliance with federal requirements for allowable activities/allowable costs, the Organization must have complete accounting records, follow approved budgets, and file required reporting forms in a timely and accurate manner. The Organization has not complied with this requirement. Context: As outlined in the award #48113, only 33.33% of Executive Director’s wages can be charged to the grant. In 1 of the payroll selections to test for allowable activity and costs, it was noted that 100% of the Executive Director’s compensation for the pay period tested was being charged to the grant. Cause: Management did not have controls in place to monitor grant requirements for allowable payroll expenditures under the federal award. Effect: The overbilling of executive director compensation resulted in known questioned costs of $2,028. Recommendation: Establish a system of controls to review FSR submissions for grant compliance prior to submission. Views of Responsible Officials and Planned Corrective Action: The chief financial officer will compare the FSR to the grant before submission to ensure allowable payroll is submitted.

Corrective Action Plan

The chief financial officer will compare the FSR to the grant before submission.

Categories

Allowable Costs / Cost Principles Reporting Significant Deficiency

Other Findings in this Audit

  • 1221252 2024-004
    Material Weakness Repeat
  • 1221253 2024-005
    Material Weakness Repeat
  • 1221254 2024-006
    Material Weakness Repeat
  • 1221255 2024-007
    Material Weakness Repeat
  • 1221256 2024-008
    Material Weakness Repeat
  • 1221257 2024-009
    Material Weakness Repeat
  • 1221258 2024-004
    Material Weakness Repeat
  • 1221259 2024-005
    Material Weakness Repeat
  • 1221260 2024-006
    Material Weakness Repeat
  • 1221261 2024-007
    Material Weakness Repeat
  • 1221262 2024-008
    Material Weakness Repeat
  • 1221263 2024-009
    Material Weakness Repeat
  • 1221264 2024-004
    Material Weakness Repeat
  • 1221265 2024-005
    Material Weakness Repeat
  • 1221266 2024-006
    Material Weakness Repeat
  • 1221267 2024-007
    Material Weakness Repeat
  • 1221269 2024-009
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.959 Substance Abuse Prevention & Treatment Block Grant $106,407
93.959 Block Grants for Prevention and Treatment of Substance Abuse $92,707